Genetic factors in systemic sclerosis

Arthritis Research and Therapy

Volumn 9, Issue SUPPL. 2, 2007, Pages

  Mayes, Maureen D ^a   Trojanowska, Maria ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; AUTOANTIBODY; COLLAGEN; HLA ANTIGEN CLASS 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR FLI 1;

ANGIOGENESIS; CHROMOSOME ANALYSIS; DISEASE COURSE; ENDOTHELIUM CELL; EPIGENETICS; FAMILIAL DISEASE; FIBROBLAST; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOME ANALYSIS; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; SCLERODERMA; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULAR FIBROSIS; ANIMAL; GENE EXPRESSION PROFILING; GENETIC LINKAGE; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; LINKAGE (GENETICS); SCLERODERMA, SYSTEMIC;

EID: 35348933363     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2189     Document Type: Review

References (41)

1. Arnett FC Cho M Chatterjee S Aguilar MB Reveille JD Mayes MD Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts Arthritis Rheum 2001 44 1359-1362 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S 11407695
2. Englert H Small-McMahon J Chambers P O'Connor H Davis K Manolios N White R Dracos G Brooks P Familial risk estimation in systemic sclerosis Aust N Z J Med 1999 29 36-41 10200811
3. Assassi S Arnett FC Reveille JD Gourh P Mayes MD Clinical, immunological, and genetic features of familial systemic sclerosis Arthritis Rheum 2007 17530643
4. Feghali-Bostwick C Medsger TA Wright TM Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies Arthritis Rheum 2003 48 1956-1963 10.1002/art.11173 12847690
5. Zhou X Tan FK Wang N Xiong M Maghidman S Reveille JD Milewicz DM Chakraborty R Arnett FC Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence Arthritis Rheum 2003 48 2585-2592 10.1002/ art.11220 13130478
6. Lee YH Nath SK Systemic lupus erythematosus susceptibility loci defined by genome scan meta-analysis Hum Genet 2005 118 434-443 10.1007/ s00439-005-0073-1 16208513
7. Etzel CJ Chen WV Shepard N Jawaheer D Cornelis F Seldin MF Gregersen PK Amos CI for the North American Rheumatoid Arthritis, Consortium Genome-wide meta-analysis for rheumatoid arthritis Hum Genet 2006 119 634-641 10.1007/s00439-006-0171-8 16612613
8. Assassi S Tan FK Genetics of scleroderma: Update on single nucleotide polymorphism analysis and microarrays Curr Opin Rheumatol 2005 17 761- 767 10.1097/01.bor.0000179943.27777.b1 16224255
9. Fatini C Gensini F Sticchi E Battaglini B Angotti C Conforti ML Generini S Pignone A Abbate R Matucci-Cerinic M High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis Am J Med 2002 112 540-544 10.1016/S0002-9343(02)01069-0 12015245
10. Allanore Y Borderie D Lemarechal H Ekindjian OG Kahan A Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients Clin Chim Acta 2004 350 51-55 10.1016/j.cccn.2004.07.008 15530459
11. Assassi S Mayes MD McNearney T Fischbach M Reveille JD Arnett FC Tan FK Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis Am J Med 2005 118 907-911 10.1016/j.amjmed.2005.01.055 16084185
12. Zhou X Tan FK Reveille JD Wallis D Milewicz DM Ahn C Wang A Arnett FC Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma Arthritis Rheum 2002 46 2990-2999 10.1002/art.10601 12428242
13. Lagan AL Pantelidis P Renzoni EA Fonseca C Beirne P Taegtmeyer AB Denton CP Black CM Wells AU du Bois RM et al. Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma Rheumatology (Oxford) 2005 44 197-201 10.1093/rheumatology/keh460 15546965
14. Gregersen PK Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond Immunol Rev 2005 204 74-86 10.1111/ j.0105-2896.2005.00243.x 15790351
15. Gourh P Tan FK Assassi S Ahn CW McNearney TA Fischbach M Arnett FC Mayes MD Association of the PTPN 22 R620 polymorphism with anti-topoisomerase 1- and anticentromere antibody-positive systemic sclerosis Arthritis Rheum 2006 54 3945-3953 10.1002/art.22196 17133608
16. Balada E Simeon-Aznar CP Serrano-Acedo S Martinez-Lostao L Selva-Callaghan A Fonollosa-Pla V Vilardell-Tarres M Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis Clin Exp Rheum 2006 24 321-324
17. Wipff J Allanore Y Kahan A Meyer O Mouthon L Guillevin L Pierlot C Glikmans E Bardin T Boileau C et al. Lack of association between the protein tyrosine phosphatase non-receptor 22 (PTPN22)* 20W allele and systemic sclerosis in the French Caucasian population Ann Rheum Dis 2006 65 1230-1232 10.1136/ard.2005.048181 16464986
18. Gregersen PK Batliwalla F PTPN22 and rheumatoid arthritis: Gratifying replication Arthritis Rheum 2005 52 1952-1955 10.1002/art.21125 15986339
19. Autieri MV Kelemen S Thomas BA Feller ED Goldman BI Eisen HJ Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy Circulation 2002 106 2218-2223 10.1161/01.CIR.0000035652.71915.00 12390951
20. Autieri MV Carbone CM Overexpression of allograft inflammatory factor-1 promotes proliferation of vascular smooth muscle cells by cell cycle deregulation Arterioscler Thromb Vasc Biol 2001 21 1421-1426 11557666
21. Del Galdo F Maul GG Jimenez SA Artlett CM Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta Arthritis Rheum 2006 54 2616-2625 10.1002/art.22010 16868985
22. Gardner H Shearstone JR Bandaru R Crowell T Lynes M Trojanowska M Pannu J Smith E Jablonska S Blaszczyk M et al. Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts Arthritis Rheum 2006 54 1961-1973 10.1002/art.21894 16736506
23. Tan FK Zhou X Marcum C Gourh P Mayes MD Jin L Arnett FC Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients Rheumatology (Oxford) 2006 45 694-702 10.1093/rheumatology/kei244 16418202
24. Alkassab F Gourh P Tan FK McNearney T Fischbach M Arnett FC Mayes MD Allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody seropositive systemic sclerosis Rheumatology (Oxford) 2007 17522098
25. Mayes MD Ahn C Arnett FC Reveille JD HLA class II associations in systemic sclerosis (SSc) from the Scleroderma Family Registry and DNA Repository Arthritis Rheum 2005 Suppl S582
26. Zhang L Eddy A Teng YT Fritzler M Kluppel M Melet F Bernstein A An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes Mol Cell Biol 1995 15 6961-6970 230951 8524263
27. Kubo M Czuwara-Ladykowska J Moussa O Markiewicz M Smith E Silver RM Jablonska S Blaszczyk M Watson DK Trojanowska M Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin Am J Pathol 2003 163 571-581 1868228 12875977
28. Czuwara-Ladykowska J Shirasaki F Jackers P Watson DK Trojanowska M Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway J Biol Chem 2001 276 20839-20848 10.1074/ jbc.M010133200 11278621
29. Wang Y Fan PS Kahaleh B Association between enhanced type 1 collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts Arthritis Rheum 2006 54 3945-3953 10.1002/art.21948 17133608
30. Nakerakanti SS Kapanadze B Yamasaki M Markiewicz M Trojanowska M Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program J Biol Chem 2006 281 25259-25269 10.1074/jbc.M600466200 16829517
31. van der Slot AJ Zuurmond AM Bardoel AF Wijmenga C Pruijs HE Sillence DO Brinckmann J Abraham DJ Black CM Verzijl N et al. Identification of PLOD23 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis J Biol Chem 2003 278 40967-40972 10.1074/jbc.M307380200 12881513
32. Spyropoulos DD Pharr PN Lavenburg KR Jackers P Papas TS Ogawa M Watson DK Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor Mol Cell Biol 2000 20 5643-5652 86032 10891501 10.1128/MCB.20.15.5643-5652.2000
33. Hanahan D Signaling vascular morphogenesis and maintenance Science 1997 277 48-50 10.1126/science.277.5322.48 9229772
34. Koch AE Distler O Vasculopathy and disordered angiogenesis in selected rheumatic diseases: Rheumatoid arthritis and systemic sclerosis Arthritis Res Ther 2007 9 Suppl 2 S3
35. Yamasaki M Kapanadze B Markiewicz M Trojanowska M Down-regulation Of fli1 in human microvascular endothelial cells promotes cell survival and leads to cord formation in 3D collagen gels The Proceedings of Miami Nature Biotechnology Winter Symposium. The cell cycle, chromosomes and cancer Miami, Florida, USA 2006 17 http://www.med.miami.edu/mnbws/ documents/06Yamasaki.pdf
36. Benjamin LE Golijanin D Itin A Pode D Keshet E Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J Clin Invest 1999 103 159-165 407882 9916127
37. Sato H Lagan A Alexopoulou C Vassilakis DA Ahmad T Pantelidis P Veeraraghavan S Renzoni E Denton C Black C et al. The TNF863A allele strongly associates with anticentromere antibody positivity in scleroderma Arthritis Rheum 2004 50 558-564 10.1002/art.20065 14872499
38. Tolusso B Fabris M Caporali R Cuomo G Isola M Soldano F Montecucco C Valentini G Ferraccioli G -238 and +489 TNF alpha along with TNFRII gene polymorphisms associate with diffuse phenotype in patients with systemic sclerosis Immunol Lett 2005 96 103-108 10.1016/j.imlet.2004.08.002 15585313
39. Karrer S Bosserhoff AK Weiderer P Distler O Landthaler M Szeimies RM Muller-Ladner U Scholmerich J Hellerbrand C The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis J Invest Dermatol 2005 124 92-98 10.1111/j.0022-202X.2004.23512.x 15654958
40. Kawaguchi Y Tochimoto A Ichikawa N Harigai M Hara M Kotake S Kitamura Y Kamatani N Association of IL1A gene polymorphism with susceptibility to and severity of systemic sclerosis in the Japanese population Arthritis Rheum 2003 48 186-192 10.1002/art.10736 12528118
41. Hutyrova B Lukac J Bosak V Buc M du Bois R Petrek M Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis J Rheumatol 2004 31 81-84 14705223